| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aclaris Therapeutics Inc (NASDAQ: ACRS)
ACRS Technical Analysis
5
| As on 9th Jun 2023 ACRS STOCK Price closed @ 9.39 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 14.83 & Strong Sell for SHORT-TERM with Stoploss of 12.94 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ACRSSTOCK Price
| Open | 9.30 | Change | Price | % |
| High | 9.40 | 1 Day | 0.11 | 1.19 |
| Low | 9.16 | 1 Week | 1.04 | 12.46 |
| Close | 9.39 | 1 Month | 0.76 | 8.81 |
| Volume | 259600 | 1 Year | -5.12 | -35.29 |
| 52 Week High 18.37 | 52 Week Low 7.07 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ACRS Daily Charts |
ACRS Intraday Charts |
Whats New @ Bazaartrend |
ACRS Free Analysis |
|
|
ACRS Important Levels Intraday
| RESISTANCE | 9.85 |
| RESISTANCE | 9.70 |
| RESISTANCE | 9.61 |
| RESISTANCE | 9.52 |
| SUPPORT | 9.26 |
| SUPPORT | 9.17 |
| SUPPORT | 9.08 |
| SUPPORT | 8.93 |
ACRS Forecast May 2024
| 4th UP Forecast | 16.92 |
| 3rd UP Forecast | 14.51 |
| 2nd UP Forecast | 13.01 |
| 1st UP Forecast | 11.52 |
| 1st DOWN Forecast | 7.26 |
| 2nd DOWN Forecast | 5.77 |
| 3rd DOWN Forecast | 4.27 |
| 4th DOWN Forecast | 1.86 |
ACRS Weekly Forecast
| 4th UP Forecast | 13.24 |
| 3rd UP Forecast | 12.01 |
| 2nd UP Forecast | 11.24 |
| 1st UP Forecast | 10.48 |
| 1st DOWN Forecast | 8.30 |
| 2nd DOWN Forecast | 7.54 |
| 3rd DOWN Forecast | 6.77 |
| 4th DOWN Forecast | 5.54 |
ACRS Forecast2024
| 4th UP Forecast | 34.81 |
| 3rd UP Forecast | 26.66 |
| 2nd UP Forecast | 21.62 |
| 1st UP Forecast | 16.58 |
| 1st DOWN Forecast | 2.2 |
| 2nd DOWN Forecast | -2.84 |
| 3rd DOWN Forecast | -7.88 |
| 4th DOWN Forecast | -16.03 |
Aclaris Therapeutics Inc ( NASDAQ USA Symbol : ACRS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ACRS Business Profile
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel, small molecule therapeutics to address the needs of patients with immuno-inflammatory diseases. The company has a multi-stage portfolio of drug candidates powered by a research and development engine exploring protein kinase regulation. Its products pipeline includes ATI-450, an investigational oral, novel, small molecule selective MK2 inhibitor compound, which is being developed as a treatment for moderate to severe rheumatoid arthritis and additional immuno-inflammatory diseases; ATI-1777, an investigational topical soft JAK 1/3 inhibitor compound, which is being developed as a treatment for moderate to severe atopic dermatitis; and ATI-2138, an investigational oral ITK/TXK/JAK3 inhibitor compound, which is being developed as a treatment for psoriasis and/or inflammatory bowel disease. It also provides contract research services. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania. Address: 640 Lee Road, Wayne, PA, United States, 19087
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service